Vaccine (Adjuvants)

LE WE PMID CA

Vaccine (Adjuvants)

11025

Impfstoff (Adjuvans)

CpG Oligonucleotides

Flagellin

Grp170

Interleukin24 MDA7

Monophosphoryl lipid A

T cell (CD4pos)

T cell (Th17)

TLR5

TLR7

TLR8

Toll like receptor

Vaccine (Adjuvants)

Vaccine (Dendritic cell)

Vaccine (Oncology)

2008 1	Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24. [18483274] Cancer Res 68(10): 3890-8 (2008)
2009 2	Adjuvants for malaria vaccines. [19691556] Parasite Immunol 31(9): 520-8 (2009)
2004 3	Aluminium compounds for use in vaccines. [15479435] Immunol Cell Biol 82(5): 497-505 (2004)
2004 4	Vaccine adjuvants: current state and future trends. [15479434] Immunol Cell Biol 82(5): 488-96 (2004)
2007 5	How do adjuvants work? Important considerations for new generation adjuvants. [18031690] Immunity 27(5): 687-90 (2007)
2011 6	Innate immunity and adjuvants. [21893536] Philos Trans R Soc Lond B Biol Sci 366(1579): 2748-55 (2011)
2011 7	New developments in vaccine research--unveiling the secret of vaccine adjuvants. [21955847] Discov Med 12(64): 195-204 (2011)
2008 8	Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. [18668203] Cell Mol Life Sci 65(20): 3231-40 (2008)
2009 9	Pharmacologic and chemical adjuvants in tumor virotherapy. [19462957] Chem Rev 109(7): 3125-40 (2009)
2010 10	Regulation of CD4 T-cell receptor diversity by vaccine adjuvants. [20331477] Immunology 130(1): 16-22 (2010)
2002 11	Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development. [12082305] Jpn J Infect Dis 55(2): 37-44 (2002)
2011 12	Efficacy and safety of vaccine adjuvants: a review from a pharmaceutical perspective. [22129865] Yakugaku Zasshi 131(12): 1721-2 (2011)
2010 13	Toll-like receptor agonists: are they good adjuvants? [20693851] Cancer J 16(4): 382-91 (2010)
2011 14	Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles. [21861904] Chem Cent J 5(1): 48 (2011)
2010 15	Flagellin as an adjuvant: cellular mechanisms and potential. [21048152] J Immunol 185(10): 5677-82 (2010)
2011 16	Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants. [21584443] Braz J Med Biol Res 44(6): 500-13 (2011)
2011 17	Virus-like particles: innate immune stimulators. [21506637] Expert Rev Vaccines 10(4): 409-11 (2011)
2011 18	ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation. [21506635] Expert Rev Vaccines 10(4): 401-3 (2011)
2011 19	TLR-7 and -8 agonists as vaccine adjuvants. [21506636] Expert Rev Vaccines 10(4): 405-7 (2011)
2011 20	Genital delivery of virus-like particle and pseudovirus-based vaccines. [21919611] Expert Rev Vaccines 10(9): 1245-8 (2011)
2009 21	IL-12 as an adjuvant for the enhancement of protective humoral immunity. [19397407] Expert Rev Vaccines 8(5): 515-8 (2009)
2010 22	Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant. [20370629] Crit Rev Immunol 30(2): 189-99 (2010)
2009 23	Adjuvants and delivery technologies. [19556878] Hum Vaccin 5(10): 667-70 (2009)
2010 24	Designing vaccines based on biology of human dendritic cell subsets. [21029958] Immunity 33(4): 464-78 (2010)
2010 25	The ABC of clinical and experimental adjuvants--a brief overview. [19895847] Immunol Lett 128(1): 29-35 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vaccine (Adjuvants).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vaccine (Adjuvants).php on line 92